UnitedHealth Group UNH releases its next round of earnings this Wednesday, January 15. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.
Earnings and Revenue
Sell-side analysts expect UnitedHealth Group's EPS to be near $3.78 on sales of $61.04 billion.
In the same quarter last year, UnitedHealth Group reported EPS of $3.28 on revenue of $58.42 billion. The analyst consensus estimate would represent a 15.24% increase in the company's EPS figure. Revenue would be up 4.49% from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
| EPS Estimate | 3.750 | 3.450 | 3.59 | 3.21 |
| EPS Actual | 3.880 | 3.600 | 3.730 | 3.28 |
Stock Performance
For a full 12 months, the return has risen by 15.42%. Given that these returns are generally positive, long-term shareholders are probably relaxed going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The popular rating by analysts on UnitedHealth Group stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
UnitedHealth Group is scheduled to hold a conference call at 8:45 a.m. ET and it can be accessed here: https://www.unitedhealthgroup.com/investors.html
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
